Last reviewed · How we verify
NCT07053930
Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin
NA trial testing Intraumbilical oxytocin in Labor in 100 participants. Completed in 31 March 2025.
31 March 2025
Quick facts
| Lead sponsor | RESnTEC, Institute of Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 October 2024 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Intraumbilical oxytocin — full drug profile →
- Intravenous oxytocin — full drug profile →
Conditions studied
- Labor — all drugs for Labor →
Sponsor
RESnTEC, Institute of Research
Who can join
Adults 18 to 40, female only, with Labor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is always a debate for choosing the best method for management of the third stage of labour (TSL) in the general practice for reducing the duration of TSL. Although intravenous oxytocin is more extensively used in general practice for managing TSL than intraumbilical, it still needs to be properly investigated among local populations and in local settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07053930
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Labor
Currently open trials in the same condition.
- NCT06436859 — The Effect of Stress Ball on Labor Pain, Anxiety and Satisfaction in Labor · NA · recruiting
Other RESnTEC, Institute of Research trials
Trials by the same sponsor.
- NCT07229885 — Comparison of Early Versus Late Trophic Feeding · NA · completed
- NCT07052136 — Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus · NA · completed
- NCT06532409 — Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone · NA · not yet recruiting
- NCT07050615 — Comparison of the Frequency of Post-Operative Pain of Continuous Versus Interrupted Suturing Techniques in Episiotomy · NA · completed
- NCT07163585 — Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07053930 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RESnTEC, Institute of Research
- Last refreshed: 8 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07053930.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing